scholarly journals Short‐term prognostic implications of serum and urine neutrophil gelatinase‐associated lipocalin in acute heart failure: findings from the AKINESIS study

2020 ◽  
Vol 22 (2) ◽  
pp. 251-263 ◽  
Author(s):  
Nicholas Wettersten ◽  
Yu Horiuchi ◽  
Dirk J. Veldhuisen ◽  
Christian Mueller ◽  
Gerasimos Filippatos ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Short Term ◽  
Neutrophil Gelatinase Associated Lipocalin ◽  
Prognostic Implications ◽  
Neutrophil Gelatinase ◽  
Serum And Urine

Biomarkers in acute heart failure

2015 ◽  
Author(s):  
Rajiv Choudhary ◽  
Kevin Shah ◽  
Alan Maisel
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Natriuretic Peptides ◽  
Health Care Systems ◽  
Medical Problem ◽  
National Health Care ◽  
Neutrophil Gelatinase Associated Lipocalin ◽  
Acute Dyspnoea ◽  
Care Systems ◽  
Neutrophil Gelatinase

Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriuretic peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.

scholarly journals Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure

2013 ◽  
Vol 165 (1) ◽  
pp. 51-55 ◽  
Author(s):  
Margarida Alvelos ◽  
Patrícia Lourenço ◽  
Carla Dias ◽  
Marta Amorim ◽  
Joana Rema ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Prognostic Value ◽  
Neutrophil Gelatinase Associated Lipocalin ◽  
Neutrophil Gelatinase

Biomarkers in acute heart failure

2018 ◽  
Author(s):  
Rajiv Choudhary ◽  
Kevin Shah ◽  
Alan Maisel
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Health Care Systems ◽  
Medical Problem ◽  
National Health Care ◽  
Neutrophil Gelatinase Associated Lipocalin ◽  
Acute Dyspnoea ◽  
Care Systems ◽  
Neutrophil Gelatinase ◽  
The Ideal

Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriureticfc peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.

scholarly journals Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation

2013 ◽  
Vol 8 ◽  
pp. BMI.S11479 ◽  
Author(s):  
Meyeon Park ◽  
Eric Vittinghoff ◽  
Kathleen D. Liu ◽  
Michael G. Shlipak ◽  
Chi-yuan Hsu
Keyword(s):  
Heart Failure ◽  
Renal Function ◽  
Acute Heart Failure ◽  
Kidney Injury ◽  
Renal Recovery ◽  
Neutrophil Gelatinase Associated Lipocalin ◽  
Urine Biomarkers ◽  
Heart Failure Exacerbation ◽  
Kidney Injury Molecule 1 ◽  
Neutrophil Gelatinase

Individuals with acute heart failure exacerbation often experience a deterioration in renal function. We sought to determine whether this deterioration is ischemic in nature and detectable by sensitive urine biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1). We measured serial biomarker levels and evaluated the associations of these biomarkers with renal recovery in a cohort of hospitalized patients with acute heart failure exacerbation.

Sign in / Sign up

Export Citation Format

Share Document